Group B Streptococcus: The Pregnant Woman and Her Neonate

Authors

  • SUE ELLEN GAFFNEY RNC, MSN,

    Corresponding author
    1. Sue Gaffney is a perinatal clinical nurse specialist at the University of Connecticut Health Center and an assistant clinical professor at the University of Connecticut School of Nursing. She is a member of NAACOG and Sigma Theta Tau.
    Search for more papers by this author
  • LORI SALINGER RNC, MSN

    1. Lori Salinger is a perinatal clinical nurse specialist at the University of Connecticut Health Center and an assistant clinical professor at the University of Connecticut School of Nursing. She is a member of NAACOG and Sigma Theta Tau.
    Search for more papers by this author

Address for correspondence: Sue Ellen Gaffney, RN, The University of Connecticut Health Center, Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, C-2170, Farmington, CT 06032.

Abstract

Within the past 10 years, group B streptococcal disease has emerged as a major causative agent in neonatal morbidity and mortality. A brief history of this pathogen and its epidemiologic factors regarding maternal colonization and carriage is presented. Group B streptococcal disease in the neonate and concurrent treatment and prevention modalities also are presented. A case study is included. Suggestions for nursing assessment, intervention, and future considerations are offered.

Ancillary